|
Observational Cohort to Assess Therapeutic Efficacy and Emergence of HIV Drug Resistance following Initiation of Tenofovir-Lamivudine-Dolutegravir (TLD)
|
Research Initiative
|
CDC
|
NIAID
|
This is a study of the safety, adherence, and efficacy of a fixed-dose combination of drug tenofovir/lamivudine/dolutegravir (TLD) among HIV patients, including those co-infected with tuberculosis, receiving care at PEPFAR (President’s Emergency Plan for AIDS Relief) funded sites in resource limited countries.
|
|
Occupational Exposure Assessment of a-Pinene and related Monoterpenes
|
Research Initiative
|
CDC, FDA
|
NIEHS
|
This research will define the range of exposures present across several industries that routinely handle monoterpene compounds, to determine which working populations are most at risk of elevated exposures to monoterpenes.
|
|
Occupational Exposure Assessment of Emerging Per- and Polyfluoroalkyl Substances (PFAS)
|
Research Initiative
|
CDC
|
NIEHS
|
The primary objectives of this study are to identify PFAS compounds currently in use in commerce or industry and the companies, industries, and worker populations who are manufacturing, processing, or using PFAS products and to conduct targeted occupational exposure assessments in high- and moderate-PFAS volume industries. Based on the results of the exposure assessment, secondary objectives of this study are to assess health effects associated with PFAS exposure.
|
|
Oceans and Human Health program
|
Research Initiative
|
Not Reported
|
NIEHS
|
NIEHS and NSF jointly fund Centers for Oceans and Human Health, which provide a collaborative opportunity across biomedical, physical and oceanographic, and environmental sciences to address public health concerns related to ocean or Great Lakes exposures (harmful algal blooms, microplastics, seafood safety, etc.).
|
|
ODP Prevention Scientific Interest Groups (SIGs)
|
Committee, Work group, Advisory group, or Task Force
|
AHRQ, CDC, FDA, OASH
|
NCI, NHLBI, NICHD, NIDDK, NIEHS, NIMHD, NINR, OD/DPCPSI/OBSSR, OD/DPCPSI/ODP
|
The Office of Disease Prevention (ODP) Prevention Scientific Interest Groups (SIGs) develop collaborative research initiatives to address unmet prevention research needs. To avoid overlap with other collaborative research planning groups, they focus on areas where there are no existing collaborative NIH-wide or federal groups.
|
|
Office of AIDS Research Advisory Council
|
Committee, Work group, Advisory group, or Task Force
|
CDC
|
NIAID, OD/DPCPSI, OD/DPCPSI/OAR
|
The Office of AIDS Research Advisory Council (OARAC) provides advice to the Office of AIDS Research (OAR) Director on the planning, coordination, and evaluation of research and other HIV/AIDS activities conducted or supported by the National Institutes of Health (NIH). The OARAC advises the Secretary of Health and Human Services, the Assistant Secretary for Health, the Director of NIH, and the Director of OAR on HIV/AIDS research programs and the development and annual review of the comprehensive NIH Strategic Plan for HIV and HIV-Related Research.
|
|
Office of the Secretary Patient-Centered Outcomes Research Trust Fund Strategic Plan Implementation
|
Committee, Work group, Advisory group, or Task Force
|
ASPE
|
NICHD
|
This group focuses on developing and overseeing implementation activities for the OS-PCORTF Strategic Plan. https://aspe.hhs.gov/os-pcortf-strategic-plan-2020-2029
|
|
OJP/CDC MDI-IWG
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA, HRSA, SAMHSA
|
NCI, NIDA
|
Medicolegal death investigation workgroups with CDC and DOJ leads.
|
|
Older Individuals Collaborative on Nutrition
|
Meeting/ Workshop
|
ACL, AHRQ, CDC, CMS, FDA, HRSA, IHS, IOS, IOS/ODPHP, OASH, OS
|
NIA, OD/DPCPSI/ODS, OD/DPCPSI/ONR
|
Nutritionists, communications professionals, and service providers from across the government discuss programs and materials development, as well as research news.
|
|
ONC Health Information Technology Advisory Committee (HITAC)
|
Committee, Work group, Advisory group, or Task Force
|
ONC, CDC, CMS, FDA
|
NEI
|
The Health Information Technology Advisory Committee (HITAC) was established by the 21st Century Cures Act (P.L. 114-255) and is governed by the provisions of the Federal Advisory Committee Act (FACA), P.L. 92-463, as amended, 5 U.S.C. App. 2, which sets forth standards for the formation and use of federal advisory committees. The HITAC will recommend to the National Coordinator for Health Information Technology policies, standards, implementation specifications, and certification criteria relating to the implementation of a health information technology infrastructure, nationally and locally, that advances the electronic access, exchange, and use of health information. HITAC unifies the roles of, and replaces, the Health Information Technology Policy Committee and the Health Information Technology Standards Committee that were in existence before the date of the enactment of the 21st Century Cures Act.
|